BioLine Rx Ltd (BLRX)
0.6401
+0.02
(+3.01%)
USD |
NASDAQ |
Apr 18, 16:00
0.6299
-0.01
(-1.59%)
After-Hours: 07:45
BioLine Rx Cash from Operations (TTM): -22.61M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -22.61M |
September 30, 2023 | -33.28M |
June 30, 2023 | -32.06M |
March 31, 2023 | -28.67M |
December 31, 2022 | -26.24M |
September 30, 2022 | -26.06M |
June 30, 2022 | -22.39M |
March 31, 2022 | -22.93M |
December 31, 2021 | -23.57M |
September 30, 2021 | -23.50M |
June 30, 2021 | -23.96M |
March 31, 2021 | -22.70M |
December 31, 2020 | -23.21M |
September 30, 2020 | -23.20M |
June 30, 2020 | -23.90M |
March 31, 2020 | -24.78M |
December 31, 2019 | -22.67M |
September 30, 2019 | -22.38M |
June 30, 2019 | -22.22M |
March 31, 2019 | -22.01M |
December 31, 2018 | -24.19M |
September 30, 2018 | -25.38M |
June 30, 2018 | -25.58M |
March 31, 2018 | -23.56M |
December 31, 2017 | -20.55M |
Date | Value |
---|---|
September 30, 2017 | -18.31M |
June 30, 2017 | -15.07M |
March 31, 2017 | -14.12M |
December 31, 2016 | -14.51M |
September 30, 2016 | -13.62M |
June 30, 2016 | -14.47M |
March 31, 2016 | -14.88M |
December 31, 2015 | -14.17M |
September 30, 2015 | -15.75M |
June 30, 2015 | -15.16M |
March 31, 2015 | -15.83M |
December 31, 2014 | -15.75M |
September 30, 2014 | -14.83M |
June 30, 2014 | -15.87M |
March 31, 2014 | -17.66M |
December 31, 2013 | -19.52M |
September 30, 2013 | -22.44M |
June 30, 2013 | -22.19M |
March 31, 2013 | -21.89M |
December 31, 2012 | -20.11M |
September 30, 2012 | -17.39M |
June 30, 2012 | -14.32M |
March 31, 2012 | -12.29M |
December 31, 2011 | -11.22M |
September 30, 2011 | -9.054M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-33.28M
Minimum
Sep 2023
-22.22M
Maximum
Jun 2019
-24.75M
Average
-23.50M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -18.47M |
XTL Biopharmaceuticals Ltd | -- |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -21.29M |